Catalia Health & Pfizer Collaborate To Better Understand The Consumer Journey Using AI

Catalia Health and Pfizer announced they have launched a pilot program to explore consumer behaviors outside of clinical environments. The pilot will test the affect that regular engagement with artificial intelligence (AI) has on a consumer's treatment journey. The 12-month pilot uses the Mabu® Wellness Coach, a robot that uses AI to gather insights into symptom management and medication adherence trends in select consumers.

The Mabu robot can interact with individuals using AI algorithms to engage in tailored, voice-based conversations. Mabu "talks" with consumers about how they are feeling and helps answer questions they may have about . . .